Source: Red Light Holland Corp.
  • Red Light Holland (TRIP) and NUBU Pharmaceuticals are partnering to seek the legal import of TRIP’s psilocybin microdosing capsules to Australasia
  • NUBU has applied to New Zealand’s Ministry of Health for several licenses and has distribution deals with six companies to supply medicinal cannabis products
  • The psilocybin microdosing capsules are being developed by Red Light Holland’s Montreal-based laboratory partner, CCrest Laboratories Inc.
  • NUBU Pharmaceuticals is a medical cannabis company based in New Zealand with distribution ties to Australia
  • Red Light Holland is an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home-grow kits
  • Red Light Holland (TRIP) opened trading at C$0.13

Red Light Holland (TRIP) and NUBU Pharmaceuticals seek to legally import Red Light Holland’s psilocybin microdosing capsules to Australasia.

NUBU Pharmaceuticals is a medical cannabis company based in New Zealand with distribution ties to Australia.

NUBU has submitted applications to New Zealand’s Ministry of Health to secure a ‘Licence to Deal in Controlled Drugs,’ a ‘Licence to Wholesale Medicines,’ and a Medicinal Cannabis Supply License from the Medicinal Cannabis Agency. NUBU Pharmaceuticals currently has distribution deals with six companies to supply medicinal cannabis products, as well as Canopy Growth Corporation’s Storz & Bickel GmbH for medical cannabis vaporizers.

The psilocybin microdosing capsules are being developed by Red Light Holland’s laboratory partner, CCrest Laboratories Inc., a Montreal-based cGMP pharmaceutical laboratory that holds a Controlled Drugs & Substances Dealer’s License from Health Canada. The capsules will be made out of natural psychoactive material (psilocybin + psilocin) and will undergo quality control testing, including those for dosage, certificate of analysis and stability.

“We are excited to partner with NUBU, a very established medicinal distribution company with relationships with regulatory bodies and doctors, to explore the possibility of legal import and distribution of our soon-to-be-produced microdosing capsules to Australia and New Zealand,” said Todd Shapiro, Red Light Holland CEO and Director.

“We are committed to developing a high-quality psilocybin product for microdosing that can potentially be accessible in emerging legal markets worldwide with the hope of helping those in need. This partnership is a step forward in achieving that goal.”

“We are hoping this partnership with Red Light Holland will be the start of something big, our end goal is the same as it was with medicinal cannabis, making new therapeutics available for those in need. With all the correct licensing in place in Australia and New Zealand, we are excited about next steps,” said Mark Dye, Co-founder & CEO of NUBU.

About NUBU Pharmaceuticals

NUBU Pharmaceuticals (New Zealand’s largest medicinal cannabis distribution company) specializes in the distribution of therapeutics, including cannabis and psychedelics.

About Red Light Holland

Red Light Holland continues to establish itself as a leader in the recreational drug sector, pushing for legal, responsible, and safe access to natural psychedelic truffles/mushrooms.

Red Light Holland (TRIP) opened trading at C$0.13.


More From The Market Online

Plunging microcap stock American Lithium triples project’s value

American Lithium (TSXV:LI) has released a technical report on the preliminary economic assessment for its Falchani lithium project in Peru.

Canadian GoldCamps enters deal to buy F3 Uranium subsidiary

Canadian GoldCamps (CSE:CAMP) has entered into a letter of intent with F3 Uranium to acquire F3 Uranium's wholly owned subsidiary F4 Uranium.

Rome Resources to begin drilling at Bisie North Tin Project

Rome Resources (TSXV:RMR) is set to begin extension drilling at its Bisie North Tin Project in the eastern Democratic Republic of the Congo.